欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0
单抗抑制剂

单抗抑制剂

单抗抑制性是一类广泛应用于癌症、免疫学等领域的单克隆抗体。如单克隆抗体与蛋白质特异性结合,从而刺激免疫系统攻击恶性肿瘤细胞,并通过阻断特定的细胞受体阻止肿瘤生长。它们可以抑制CD20、HER、VEGFR、TNF-α等靶点,在非霍奇金淋巴瘤、HER2阳性乳腺癌等疾病中发挥作用。CSNpharm提供多种单抗抑制剂,如Adalimumab、Bevacizumab和Rituximab等,满足您在免疫疾病和癌症领域的研究需求。

产品列表

货号 产品名称 CAS号 描述
CSN_mab1010 Rituximab 174722-31-7

Rituximab is a genetically engineered chimeric murine/human monoclonal antibody that targets CD20, a B-cell-specific surface antigen.

CSN_mab1004 Trastuzumab 180288-69-1

Trastuzumab is a humanized IgG1 monoclonal antibody that binds to subdomain IV of HER2 receptor with high affinity and specifcity, inhibiting ligand-i

CSN_mab1009 Adalimumab 331731-18-1

Adalimumab is a fully human, high-affinity, recombinant immunoglobulin G (IgG) anti-TNF alpha monoclonal antibody.

CSN_mab1033 Infliximab 170277-31-3

Infliximab is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody to TNF.

CSN_mab1012 Bevacizumab 216974-75-3

Bevacizumab is a recombinant humanized monoclonal immunoglobulin (Ig) G1 antibody that binds to all isoforms and bioactive proteolytic fragments of hu

<< PREV 1 NEXT >>
联系
我们